$204 Million is the total value of Crossvault Capital Management LLC's 77 reported holdings in Q2 2019. The portfolio turnover from Q1 2019 to Q2 2019 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IXN | Exit | iShares Global Tech ETF | $0 | – | -1,400 | -100.0% | -0.12% | – |
| DWDP | Exit | DowDuPont | $0 | – | -6,756 | -100.0% | -0.19% | – |
| REGN | Exit | Regeneron Pharmaceuti | $0 | – | -12,385 | -100.0% | -2.62% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-07-19
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Apple Computer Inc. | 35 | Q2 2022 | 6.9% |
| Amazon.com Inc. | 35 | Q2 2022 | 7.4% |
| Johnson & Johnson | 35 | Q2 2022 | 3.7% |
| Honeywell International Inc | 35 | Q2 2022 | 4.2% |
| PNC Financial Services | 35 | Q2 2022 | 4.3% |
| Nike Inc B | 35 | Q2 2022 | 4.6% |
| Rockwell Automation Inc | 35 | Q2 2022 | 3.3% |
| PepsiCo Inc. | 35 | Q2 2022 | 5.3% |
| ConocoPhillips | 35 | Q2 2022 | 3.9% |
| Pfizer Inc. | 35 | Q2 2022 | 3.8% |
View Crossvault Capital Management LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2022-08-08 |
| 13F-HR | 2022-05-05 |
| 13F-HR | 2022-02-07 |
| 13F-HR | 2021-11-09 |
| 13F-HR | 2021-08-12 |
| 13F-HR | 2021-04-28 |
| 13F-HR | 2021-02-08 |
| 13F-HR | 2020-10-21 |
| 13F-HR | 2020-08-05 |
| 13F-HR | 2020-04-17 |
View Crossvault Capital Management LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.